Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020:1219:259-293.
doi: 10.1007/978-3-030-34025-4_14.

The Bone Marrow Niche - The Tumor Microenvironment That Ensures Leukemia Progression

Bruno António Cardoso  1
Affiliations
Review

The Bone Marrow Niche - The Tumor Microenvironment That Ensures Leukemia Progression

Bruno António Cardoso. Adv Exp Med Biol. 2020.

Abstract

The human body requires a constant delivery of fresh blood cells that are needed to maintain body homeostasis. Hematopoiesis is the process that drives the formation of new blood cells from a single stem cell. This is a complex, orchestrated and tightly regulated process that occurs within the bone marrow. When such process is faulty or deregulated, leukemia arises, develops and thrives by subverting normal hematopoiesis and availing the supplies of this rich milieu.In this book chapter we will describe and characterize the bone marrow microenvironment and its key importance for leukemia expansion. The several components of the bone marrow niche, their interaction with the leukemic cells and the cellular pathways activated within the malignant cells will be emphasized. Finally, novel therapeutic strategies to target this sibling interaction will also be discussed.

Keywords: Bone marrow; Dual-targeting; Hematopoiesis; Leukemia; Microenvironment; Signaling pathways.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Agarwal P, Bhatia R (2015) Influence of bone marrow microenvironment on leukemic stem cells: breaking up an intimate relationship. Adv Cancer Res 127:227–252. https://doi.org/10.1016/bs.acr.2015.04.007 . S0065-230X(15)00035-4 [pii] - DOI - PubMed
    1. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC (1997) The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 185(1):111–120. https://doi.org/10.1084/jem.185.1.111 - DOI - PubMed - PMC
    1. Allouche M, Charrad RS, Bettaieb A, Greenland C, Grignon C, Smadja-Joffe F (2000) Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells. Blood 96(3):1187–1190 - DOI - PubMed
    1. Andersson ER, Sandberg R, Lendahl U (2011) Notch signaling: simplicity in design, versatility in function. Development 138(17):3593–3612. https://doi.org/10.1242/dev.063610 . 138/17/3593 [pii] - DOI - PubMed
    1. Andreeff M, Zeng Z, Kelly MA, Wang R-y, McQueen T, Duvvuri S, Nowshah G, Borthakur G, Burger JA, Kadia TM, Jabbour E, Cortes JE, Kantarjian HM, Konopleva M (2012) Mobilization and elimination of FLT3-ITD+ Acute Myelogenous Leukemia (AML) stem/progenitor cells by Plerixafor/G-CSF/Sorafenib: results from a phase I trial in relapsed/refractory AML patients. Blood 120:142 - DOI

LinkOut - more resources